438 related articles for article (PubMed ID: 8135494)
1. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
2. [Oncogenes and their significance for head and neck cancers].
Issing WJ; Wustrow TP; Heppt W
HNO; 1992 Aug; 40(8):283-91. PubMed ID: 1517116
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of head and neck cancer.
Brachman DG
Semin Oncol; 1994 Jun; 21(3):320-9. PubMed ID: 7911603
[No Abstract] [Full Text] [Related]
4. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
5. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in head and neck cancer.
Somers KD; Schechter GL
Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191
[TBL] [Abstract][Full Text] [Related]
7. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
9. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
[TBL] [Abstract][Full Text] [Related]
10. The role of oncogenes in human neoplasia.
Aaronson SA; Tronick SR
Important Adv Oncol; 1985; ():3-15. PubMed ID: 3916746
[No Abstract] [Full Text] [Related]
11. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and uterine function.
Stancel GM; Baker VV; Hyder SM; Kirkland JL; Loose-Mitchell DS
Oxf Rev Reprod Biol; 1993; 15():1-42. PubMed ID: 8336974
[No Abstract] [Full Text] [Related]
13. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
Bortner DM; Langer SJ; Ostrowski MC
Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
[TBL] [Abstract][Full Text] [Related]
14. [Oncogenic activity of head and neck tumors].
Basterra J; Armengot M; Martorell M; Barona R; Montalt J
An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
[TBL] [Abstract][Full Text] [Related]
15. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine.
Hsieh LL; Hsiao WL; Peraino C; Maronpot RR; Weinstein IB
Cancer Res; 1987 Jul; 47(13):3421-4. PubMed ID: 3555772
[TBL] [Abstract][Full Text] [Related]
16. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
[TBL] [Abstract][Full Text] [Related]
17. [Oncogenes and anti-oncogenes in breast cancer].
Birnbaum D; Gaudray P
Bull Cancer; 1989; 76(7):677-87. PubMed ID: 2573395
[TBL] [Abstract][Full Text] [Related]
18. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
20. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
